Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial

Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-randomized controlled open-label trial, we co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamp, Jan C., Fuge, Jan, Ringshausen, Felix C., Grote-Koska, Denis, Brand, Korbinian, Graalmann, Lukas, Vonberg, Ralf-Peter, Welte, Tobias, Rademacher, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998425/
https://www.ncbi.nlm.nih.gov/pubmed/33799542
http://dx.doi.org/10.3390/antibiotics10030292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998425/
https://www.ncbi.nlm.nih.gov/pubmed/33799542
http://dx.doi.org/10.3390/antibiotics10030292

Ejemplares similares